Should IMPower010 results be extrapolated to superior sulcus tumors treated with chemoradiation and surgery?

Are you incorporating PDL1/molecular testing into adjuvant treatment decisions for superior sulcus NSCLC?

• No, since these patients were not eligible for the respective trials
• No, I'm not running NGS in superior sulcus NSCLC until metastatic
• Yes, would treat with osimertinib if EGFR+ or atezolizumab if PDL1+
• Yes, but only if EGFR+ (would add osimertinib)
• Yes, but only if PDL1+ (would add atezolizumab)
• Other